Patent · US Active

Oral tablet compositions of dexlansoprazole

US8563035B2 · kind B2 · utility

6Cited by
0References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2011
Grant dateOct 22, 2013
Priority date
Expiry dateMay 5, 2031

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P1/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Oral tablet compositions of dexlansoprazole or pharmaceutically acceptable salts or hydrated forms thereof having a gradual release and processes for the manufacture of the tablet composition and its use in the treatment of gastrointestinal disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.